Literature DB >> 8444235

Probable role of Streptococcus pyogenes in Kawasaki disease.

T Akiyama1, K Yashiro.   

Abstract

Over the past 25 years, the clinical course of Kawasaki disease has been defined, the prevalence and nature of the cardiovascular effects widely understood, and pathological changes in the most severe cases well described. However, the aetiology and pathogenesis of this puzzling disease have remained unclear, thus specific therapy is not yet available. Because of some close clinical similarities between this disease and streptococcal scarlet fever, particular attention has been paid to the possible role of Streptococcus pyogenes as an aetiological agent in this illness. Until now, however, group A beta-haemolytic streptococci have never been consistently isolated from any patients; in addition, the titre of anti-streptolysin 0 is not raised, and lack of response to antibiotics is a feature of this disease. Our long series of investigations over more than 10 years, which will be covered in the present review, were performed in an attempt at elucidating causative agent(s) of Kawasaki disease. This has led to our firm belief in the probable role of S. pyogenes in the pathogenesis of this disease, despite the lack of fulfillment of Koch's postulates, on the basis of the following findings. Patients with Kawasaki disease recovering from the acute, febrile phase of the illness exhibited an exaggerated cell-mediated reactivity, as measured by the macrophage migration inhibition test, to group A beta-haemolytic streptococci, their pyrogenic exotoxin and streptolysin 0 as well as to several mammalian muscle cell extracts which are allegedly related antigenically to the cell wall and/or cytoplasmic membrane of S. pyogenes. Protoplast-like "spherical bodies" varying in diameter from 0.5 to 1.5 microns, and devoid of cell walls, were detected in the buffy coats of peripheral blood from patients with this disease, and stained distinctly by immuno-electron microscopy using, as a primary antibody, a rabbit antiserum to S. pyogenes- derived protoplasts, and followed by absorption with protoplasts from Staphylococcus aureus and Escherichia coli. Newborn mice infected with S. pyogenes having no capacity to confer cell-mediated immunity even in adult murine hosts, and reinfected 4-6 weeks later with another strain of the same species of bacteria which is able to elicit cellular immunity, showed a lack of humoral response to streptococcal antigens, leaving intact cell-mediated immunity. Such a biased immunological characteristic is an exact counterpart of that of Kawasaki disease patients.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8444235     DOI: 10.1007/bf02072479

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  39 in total

1.  Risk to children exposed in home to respiratory bacteria.

Authors:  H S HARVEY; M B DUNLAP
Journal:  Am J Dis Child       Date:  1962-06

2.  Haemolytic Streptococcal Infections and Acute Rheumatism.

Authors:  C A Green
Journal:  Ann Rheum Dis       Date:  1942-05       Impact factor: 19.103

3.  Possible role of Streptococcus pyogenes in mucocutaneous lymph node syndrome. XI. Immunoelectron microscopic observation of protoplast-like "spherical bodies" detected in peripheral blood of MCLS patients.

Authors:  T Akiyama; H Tamauchi; K Nakazato; K Yashiro; Y Itoh
Journal:  Acta Paediatr Jpn       Date:  1991-06

4.  Evaluation of evidence related to streptococci in the etiology of Kawasaki disease.

Authors:  S Kotani
Journal:  Prog Clin Biol Res       Date:  1987

5.  [1979-fiscal-year-survey for throat-carriers of hemolytic streptococci among children in Tokyo (author's transl)].

Authors:  T Yamaguchi; T Onogawa; Y Amano; T Iimura; N Okubo; Y Kashiwagi
Journal:  Kansenshogaku Zasshi       Date:  1982-01

6.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].

Authors:  T Kawasaki
Journal:  Arerugi       Date:  1967-03

7.  REACTIONS OF RABBITS TO NON-HEMOLYTIC STREPTOCOCCI : II. SKIN REACTIONS IN INTRAVENOUSLY IMMUNIZED ANIMALS.

Authors:  H F Swift; C L Derick
Journal:  J Exp Med       Date:  1929-04-30       Impact factor: 14.307

8.  Possible role of Streptococcus pyogenes in mucocutaneous lymph node syndrome. XII. Variable responses of platelets in MCLS seem to be explainable by streptococcal pyrogenic exotoxin.

Authors:  T Akiyama; N Osawa; K Shimanuki; K Yashiro; T Oyake
Journal:  Acta Paediatr Jpn       Date:  1991-02

9.  Possible role of Streptococcus pyogenes in mucocutaneous lymph node syndrome. VI. Heightened cellular reactivity to streptolysin-O in mice infected with S. pyogenes and in MCLS patients.

Authors:  T Akiyama; N Osawa; N Yamaura; K Yasahiro; S Hiraishi
Journal:  Acta Paediatr Jpn       Date:  1988-02

10.  An immunological relationship between the group. A streptococcus and mammalian muscle.

Authors:  J B Zabriskie; E H Freimer
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  8 in total

1.  Osteomyelitis in Kawasaki disease.

Authors:  Satya Prakash Singh; Nasir Husain Ansari; Yashwant Singh Tanwar; Masood Habib
Journal:  Indian J Pediatr       Date:  2014-05-02       Impact factor: 1.967

2.  Expression of CD180, a toll-like receptor homologue, is up-regulated in children with Kawasaki disease.

Authors:  Miyoko Imayoshi; Shuichi Yamamoto; Mamie Watanabe; Shinji Nishimura; Katsuya Tashiro; Masafumi Zaitsu; Hakaru Tasaki; Masao Kimoto; Yuhei Hamasaki; Eiichi Ishii
Journal:  J Mol Med (Berl)       Date:  2005-12-31       Impact factor: 4.599

3.  Kawasaki disease in Australia, 1993-95.

Authors:  J A Royle; K Williams; E Elliott; G Sholler; T Nolan; R Allen; D Isaacs
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

4.  The role of anti-endothelial cell antibodies in Kawasaki disease - in vitro and in vivo studies.

Authors:  E Grunebaum; M Blank; S Cohen; A Afek; J Kopolovic; P L Meroni; P Youinou; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

Review 5.  Kawasaki disease: what is the epidemiology telling us about the etiology?

Authors:  David Burgner; Anthony Harnden
Journal:  Int J Infect Dis       Date:  2005-07       Impact factor: 3.623

6.  Vasculitis induced by immunization with Bacillus Calmette-Guérin followed by atypical mycobacterium antigen: a new mouse model for Kawasaki disease.

Authors:  Tsuneyuki Nakamura; Jun-Ichi Yamamura; Hitoshi Sato; Hiroaki Kakinuma; Hiroaki Takahashi
Journal:  FEMS Immunol Med Microbiol       Date:  2007-02-12

Review 7.  Infection and vasculitis.

Authors:  Cristina C Belizna; Mohamed A Hamidou; Hervé Levesque; Loic Guillevin; Yehuda Shoenfeld
Journal:  Rheumatology (Oxford)       Date:  2009-03-03       Impact factor: 7.580

8.  Non-Typhoidal Salmonella and the Risk of Kawasaki Disease: A Nationwide Population-Based Cohort Study.

Authors:  Thomas Yen-Ting Chen; Mei-Chia Chou; Jung-Nien Lai; Lu-Ting Chiu; Renin Chang; Yao-Min Hung; James Cheng-Chung Wei
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.